Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HUBG | CTS |
|---|---|---|
| Price | $28.74 | $61.61 |
| Change today | ▼ 3.46% | ▲ 0.02% |
| Market cap | $1.76B | $1.76B |
| Return, 3 months | -37.4% | +4.2% |
| Return, year to date | -31.9% | +44.0% |
| Return, 1 year | -16.2% | +54.1% |
| P/E (TTM) | 16.5 | 25.8 |
| P/B | 1.0 | 3.1 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 1.74% | 0.26% |
| Revenue growth (YoY, latest qtr) | -6.1% | – |
| Net profit growth (YoY) | -37.9% | – |
| Gross margin | 11.1% | – |
| Operating margin | 3.5% | – |
| Net margin | 2.6% | – |
| Return on equity | – | – |
| Analyst target vs. price | +49.6% | +19.3% |
| Analyst buy share | 50% | 100% |
| RSI (14) | 23 | 66 |
| 30-day volatility | 34.3% | 19.9% |
| Max drawdown, 1 year | -44.7% | -20.3% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
